The importance of cell plasticity as a mechanism of treatment tolerance was highlighted in clinical cases of non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR) TKIs, transformed into small-cell lung cancer (SCLC). This evidence concerns the gene EGFR and small cell lung carcinoma.